{"doi":"10.1002/pbc.31811","title":"Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry","abstract":"<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Proton beam therapy (PT) offers a targeted approach to treating pediatric tumors by minimizing radiation exposure to surrounding healthy tissue. However, the specific toxicity profile associated with it remains underexplored. This study aims to investigate the incidence and risk factors of acute and late treatment‐related toxicities following PT in pediatric patients with pelvic tumors.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Using data from the Pediatric Proton Consortium Registry (PPCR), we analyzed 126 pediatric patients who underwent PT for pelvic tumors. We assessed the incidence of gastrointestinal (GI), genitourinary (GU), and musculoskeletal (MSK) toxicities at baseline, during treatment, and across follow‐up intervals.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Acute toxicities were observed in 61.9% of patients posttreatment, with new GI, GU, and MSK toxicities occurring in 54.3%, 9.7%, and 7.0% of baseline toxicity‐free patients, respectively. Follow‐up indicated that 20.6%, 22.2%, and 13.5% of patients developed late GI, GU, and MSK toxicities, respectively. Use of passive scattering proton therapy and radiation to the abdomen were significant predictors of GI toxicity development, while higher radiation dose was associated with MSK toxicity development.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our findings demonstrate the safety profile of PT among pediatric patients while identifying specific risk factors, such as passive scattering proton therapy and abdominal irradiation, that contribute to increased GI toxicity. While proton therapy appears to be a well‐tolerated treatment option, the observed toxicity rates highlight the need for continued monitoring and long‐term follow‐up.</jats:p></jats:sec>","journal":"Pediatric Blood &amp; Cancer","year":2025,"id":643383,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":647520,"name":"Daniel J. Indelicato","orcid":"0000-0001-5765-1873","position":1,"is_corresponding":false},{"id":288903,"name":"Arnold C. Paulino","orcid":"0000-0002-0269-3045","position":2,"is_corresponding":false},{"id":1674019,"name":"Stephen Mihalcik","orcid":null,"position":3,"is_corresponding":false},{"id":733835,"name":"Jae Lee","orcid":"0000-0002-4209-3239","position":4,"is_corresponding":false},{"id":607797,"name":"Ralph P. Ermoian","orcid":"0000-0002-7514-0943","position":5,"is_corresponding":false},{"id":1120008,"name":"J. Chang","orcid":"0000-0002-2059-6599","position":6,"is_corresponding":false},{"id":574667,"name":"Young Kwok","orcid":"0000-0003-1484-8507","position":7,"is_corresponding":false},{"id":1674020,"name":"John Perentesis","orcid":null,"position":8,"is_corresponding":false},{"id":964495,"name":"Stephanie M. Perkins","orcid":null,"position":9,"is_corresponding":false},{"id":1674021,"name":"Christine Hill‐Kayser","orcid":null,"position":10,"is_corresponding":false},{"id":1674022,"name":"Wael Zeina","orcid":null,"position":11,"is_corresponding":false},{"id":322326,"name":"Nadia N. Laack","orcid":"0000-0002-4385-6349","position":12,"is_corresponding":false},{"id":477587,"name":"Torunn I. Yock","orcid":"0000-0001-6408-8011","position":13,"is_corresponding":false},{"id":1674023,"name":"Patricio C. Gargollo","orcid":null,"position":14,"is_corresponding":false},{"id":1674018,"name":"Jamil Almohtasib","orcid":"0000-0002-5055-674X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry","abstract":"<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Proton beam therapy (PT) offers a targeted approach to treating pediatric tumors by minimizing radiation exposure to surrounding healthy tissue. However, the specific toxicity profile associated with it remains underexplored. This study aims to investigate the incidence and risk factors of acute and late treatment‐related toxicities following PT in pediatric patients with pelvic tumors.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Using data from the Pediatric Proton Consortium Registry (PPCR), we analyzed 126 pediatric patients who underwent PT for pelvic tumors. We assessed the incidence of gastrointestinal (GI), genitourinary (GU), and musculoskeletal (MSK) toxicities at baseline, during treatment, and across follow‐up intervals.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Acute toxicities were observed in 61.9% of patients posttreatment, with new GI, GU, and MSK toxicities occurring in 54.3%, 9.7%, and 7.0% of baseline toxicity‐free patients, respectively. Follow‐up indicated that 20.6%, 22.2%, and 13.5% of patients developed late GI, GU, and MSK toxicities, respectively. Use of passive scattering proton therapy and radiation to the abdomen were significant predictors of GI toxicity development, while higher radiation dose was associated with MSK toxicity development.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our findings demonstrate the safety profile of PT among pediatric patients while identifying specific risk factors, such as passive scattering proton therapy and abdominal irradiation, that contribute to increased GI toxicity. While proton therapy appears to be a well‐tolerated treatment option, the observed toxicity rates highlight the need for continued monitoring and long‐term follow‐up.</jats:p></jats:sec>","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"40660625","pmcid":null,"openalex_id":"https://openalex.org/W4412414767","authors":[],"funders":[],"total_grants":0,"fwci":1.5596,"citation_percentile":0.83168445,"influential_citations":0,"citation_trend":[{"year":2025,"count":1},{"year":2026,"count":1}],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31811","host_type":"publisher"},{"url":"https://doi.org/10.1002/pbc.31811","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/40660625","host_type":"repository"}],"fields_of_study":["Radiation Therapy and Dosimetry","Advanced Radiotherapy Techniques","Effects of Radiation Exposure","Humans","Proton Therapy","Child","Female","Male","Pelvic Neoplasms","Registries","Child, Preschool","Radiation Injuries","Adolescent","Follow-Up Studies","Infant","Incidence","Risk Factors","Prognosis"],"mesh_terms":["Adolescent","Child","Child, Preschool","Female","Follow-Up Studies","Humans","Infant","Male","Pelvic Neoplasms","Prognosis","Radiation Injuries","Registries","Risk Factors","Incidence","Proton Therapy"],"keywords":["Medicine","Toxicity","Genitourinary system","Proton therapy","Incidence (geometry)","Radiation therapy","Acute toxicity","Internal medicine","Abdomen","Oncology","Radiology","Pediatric Oncology","Radiation Toxicity"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-08T16:26:35.044044Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}